The genetics of human systemic lupus erythematosus

Current Opinion in Immunology

Volumn 10, Issue 6, 1998, Pages 690-696

  Harley, John B ^a   Moser, Kathy L ^a,b   Gaffney, Patrick M ^c   Behrens, Timothy W ^c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; FC RECEPTOR; HISTOCOMPATIBILITY ANTIGEN; MANNOSE BINDING PROTEIN;

ALLELE; CHROMOSOME 1Q; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032401755     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80090-3     Document Type: Article

References (63)

1. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA. 88:1991;8661-8665.
2. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med. 181:1995;453-461.
3. James JA, Harley JB. Peptide induced lupus autoimmunity in inbred strains of mice. of special interest J Immunol. 160:1998;502-508 In this report responder and nonresponder mouse strains are identified, providing another perspective from which to understand lupus autoimmunity and B cell epitope spreading that are induced following immunization with peptides.
4. Hibbs ML, Tarlington DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR. Multiple defects in the immune system of lyn-deficient mice, culminating in autoimmune disease. Cell. 83:1995;301-311.
5. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby K, Clark EA, Goodnow CC. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. of special interest Immunity. 8:1998;497-508 This paper demonstrates that the control of B cell activation, reactivity of B cells to antigen and apoptosis can tip the balance toward autoimmunity when appropriately deranged.
6. Maddison PJ, Reichlin M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum. 20:1977;819-824.
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus [Letter]. Arthritis Rheum. 25:1982;1271-1277.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [Letter]. Arthritis Rheum. 40:1997;1725.
9. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. of special interest J Clin Invest. 100:1997;3019-3026 Evidence here supports the notion that, as in any disorder, the genetics and the etiologies of lupus are expected to become, eventually, critical components of a sensible explanation of pathogenesis.
10. Grumet FC, Conkell A, Bodmer JC, Bodmer WF, McDevitt HO. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. N Engl J Med. 285:1971;193-196.
11. Schur PH. Genetics of systemic lupus erythematosus. Lupus. 4:1995;425-437.
12. Granados J, Vargas-Alarcon G, Drenkard C, Andrade F, Melin-Aldana H, Alcocer-varela J, Alarcón-Segovia D. Relationship of anticardiolipin antibodies and anti-phospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus. Lupus. 6:1997;57-62.
13. Arnett FC. The genetics of human lupus. Wallace DJ, Hahn BH. edn 5 Dubois' Lupus Erythematosus. 1997;77-117 Wilkins and Wilkins, Baltimore.
14. Harley JB, Sestak AS, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies and lymphopenia or renal disease. Arthritis Rheum. 32:1989;826-836.
15. Jarjour W, Reed AM, Gauthier J, Hunt S, Winfield JB. The 8.5-kb Pstl allele of the stress protein gene, Hsp70-2. An independent risk factor for systemic lupus erythematosus in African-Americans? Hum Immunol. 45:1996;59-63.
16. Brennan P, Hajeer A, Ong KR, Worthington J, John S, Thomson W, Silman A, Ollier B. Alleleic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 40:1997;1383-1386.
17. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol. 23:1996;1725-1728.
18. Hajeer HA, Worthington J, Davies EJ, Hillarby MC, Poulton K, Ollier WER. TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus. Tissue Antigen. 49:1997;222-227.
19. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum. 40:1997;2207-2211.
20. Slingsby JH, Norsworthy P, Pearce G, Vaishnaw AK, Issler H, Morley BJ, Walport MJ. Homozygous hereditary C1q deficiency and systemic lupus erythematosus. Arthritis Rheum. 39:1996;663-670.
21. Reid KBM. Deficiency of the first component of human complement. Rosen FS, Seligman M. Immunodeficiencies. 1993;283-293 Harwood Academic Publishers, Philadelphia.
22. Fielder AHL, Walport MJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, Hughes GRV. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Brit Med J. 286:1983;425-428.
23. Walport MJ. Complement deficiency and disease. Brit J Rheumatol. 32:1993;269-273.
24. Provost TT, Arnett FC, Reichlin M. Homozygous C2 deficiency, lupus erythematosus and anti-Ro(SS-A) antibodies. Arthritis Rheum. 26:1983;1279-1282.
25. Davies EJ, Steers G, Ollier WER, Grennan DM, Cooper RG, Hay EM, Hillarby MC. Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Brit J Rheumatol. 34:1995;221-225.
26. Kiwasaki M, Kawasaki T, Tyamashura I. Isolation and characterization of a mannose binding protein from human serum. J Biol Chem. 94:1983;937-942.
27. Ikeda K, Sannoh T, Kawasaki N, Kawwsaki T, Yamashini I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem. 262:1987;7451-7456.
28. Schweinle JE, Ezekowitz RAB, Tenner AJ, Kuhlman M, Joiner KA. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose rich isolate of Salmonella. J Clin Invest. 84:1989;1821-1829.
29. Davies EJ, Snowden N, Hillarby MC, Carthy D, Gernnan DM, Thomson W, Ollier WER. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthiritis Rheum. 38:1995;110-114.
30. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein polymorphism in black patients with systemic lupus erythematosus. Arthritis Rheum. 39:1996;2046-2051.
31. Davies EJ, The L-S, Ordi-Ros J, Snowden N, Hillarby MC, Hajeer A, Donn R, Pilar P-P, Vilardell-Tarres M, Ollier WER. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J Rheumatol. 24:1997;485-488.
32. Clark MR, Liu L, Clarkson SB, Ory PA, Goldstein IM. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J Clin Invest. 86:1990;341-346.
33. Enenkel B, Jung D, Frey J. Molecular basis of IgG Fc receptor III defect in a patient with systemic lupus erythematosus. Eur J Immunol. 21:1991;659-663.
34. Fromont P, Bettaieb A, Skouri H, Floch C, Poulet E, Duedari N, Bierling P. Frequency of the polymorphonuclear neutrophil Fc gamma receptor III deficiency in the French population and its involvement in the development of neonatal neutropenia. Blood. 79:1992;2131-2134.
35. Salmon JE, Millard S, Schachter L, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MGE, Kimberly RP. FcγRIIA alleles are heritable risk factors for lupus nephritis in African-Americans. J Clin Invest. 97:1996;1348-1354.
36. Song YW, Han C-W, Kang S-W, Baek H-J, Lee E-B, Shin C-H, Hahn BH, Tsao BP. Abnormal distribution of the Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum. 41:1998;412-426.
37. Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, Capel PJA, Westerdaal NAC, Spierenburg GT, Gmelig-Meyling FHJ, van de Winkle JGJ. Skewed distribution of the Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 39:1995;1832-1836.
38. Botto M, Theodoritis E, Thompson EM, Beynon HL, Briggs D, Isenberg DA, Walport MJ, Davies KA. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol. 104:1996;264-268.
39. Manger K, van de Winkel JG, Kalden JR, Manger B, Wentz B, Westerdaal NA, Wassmuth R, Geiger A, Rascu A, Spriewald BM, Repp R. Fc gamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum. 41:1998;1181-1189.
40. Yee AMF, Ng SC, Sobel RE, Salmon JE. FcγRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus. Arthritis Rheum. 40:1997;1180-1182.
41. Wu J, Edberg JC, Redcha PB, Bansal V, Guyre PM, Coleman K, Salmon JE, Kimberly RP. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest. 100:1997;1059-1070.
42. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human II-10 locus and systemic lupus erythematosus. Tissue Antigen. 49:1997;635-639.
43. Truner DM, Williams DM, Sanakaran D, Lazarus M, Sinnott PJ, Hutchinsin IV. An investigation of the polymorphisms in the interleukin-10 gene promoter. Eur J Immunogenet. 24:1997;1-8.
44. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 41:1998;1090-1095.
45. Llorente L, Richard-Patis Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, Alacocer-Valera J, Granados J, Bahena S, Galanuad P, Emilie D. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum. 40:1997;1429-1435.
46. Mehrian R, Quismorio FP, Strassmann G, Stimmler MM, Horowitz DA, Kitridou RC, Gauderman WJ, Morrison J, Brautbar C, Jacob CO. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum. 41:1997;596-602.
47. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol. 24:1997;2314-2317.
48. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 98:1996;1107-1113.
49. 506 mutation and anticardiolipin antibodies in systemic lupus erythematosus. Lupus. 5:1996;598-601.
50. 506〉Gln mutation in patients with antiphospholipid antibodies. Lupus. 5:1996;303-306.
51. Simantov R, Lo SK, Salmon JE, Sammaritano LR, Silverstein RL. Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies. Thromb Res. 84:1996;361-365.
52. Fijnheer R, Horbach DA, Donders RCJM, Vilé H, Oort EV, Nieuenhuis HK, Gmelig-Meijling FHJ, de Groot PG, Derksen RHWM. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost. 76:1996;514-517.
53. Bias WB, Reveille JD, Beaty TLH, Meyers DA, Arnett FC. Evidence that autoimmunity in man is a Mendelian dominant trait. Amer J Hum Genet. 39:1986;584-602.
54. Harley JB, Sheldon P, Neas B, Murphy S, Wallace DJ, Scofield RH, Shaver TS, Moser KL. Systemic lupus erythematosus: considerations for a genetic approach. J Invest Dermatol. 103:1994;144S-149S.
55. Tsao BP, Cantor RM, Kalunian KC, Chen C-J, Badsha H, Singh R, Wallace DJ, Kitridou RC, Chen S-I, Shen N, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. of special interest J Clin Invest. 99:1997;725-731 In this study, evidence for linkage to D1s229 was found in a collection of 52 sibling pairs.
56. Kono DH, Burlingame RW, Owens D, Kuramochi A, Banders RS, Balomenos D, Theofilopoulos A. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA. 91:1994;10168-10172.
57. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL. Analysis if the New Zealand Black contribution to lupus-like renal disease: multiple genes that operate in a threshold manner. J Immunol. 154:1995;2441-2447.
58. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine SLE. Immunity. 1:1994;219-229.
59. Kotzin BL. Susceptibility loci for lupus: a guiding light from murine models? J Clin Invest. 99:1997;557-558.
60. Tsao PB, Cantor RM, Grossman JM, Theophilov N, Wallace DJ, Arnett FC, Hartung K, Goldstein R, Kalunian KC, Hahn BH, Rotter JI. ADPRT alleles from chromosome 1 q41-42 linked region are associated with SLE. of outstanding interest Arthritis Rheum. 41:1998;S80 The association described here may identify the gene responsible for the linkage at D1s229. Confirmation and fine mapping studies are needed.
61. Gaffney P, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malgren ML, Rohlf KE, Ockenden TC, Messner RP, King RA, et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. of outstanding interest Proc Natl Acad Sci USA. 1998; Here, the results of genotyping 105 sibling pairs are reported.
62. Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, Bruner GR, Fox J, Kelly J, Henshall S, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. of outstanding interest Proc Natl Acad Sci USA. 1998; In this paper, putative linkages from 94 extended pedigrees are reported.
63. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, Trent JM. Clustering of non-major histocompatibility complex susceptibility loci in human autoimmune diseases. Proc Natl Acad Sci USA. 95:1998;9979-9984.